ALFA FinderBSE filing, NSE: MANGALAM. Summary written from the filing by ALFA Finder's alert engine.
Mangalam Drugs and Organics Ltd: key numbers
- Share price
- ₹28.80
- Market cap
- ₹45.59 Cr
- Revenue (annual)
- ₹232.1 Cr
- Net profit (annual)
- ₹-44.40 Cr
- P/E (TTM)
- -1.2×Sector 43.0×
- Promoter holding
- 35.65%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mangalam Drugs and Organics Ltd
All →Mangalam Drugs and Organics Q2 FY27 Results: Net Loss of ₹7.2 Cr, Loss Narrows
Mangalam Drugs and Organics Ltd reported revenue from operations of ₹79.4 Cr (+61.1% YoY) and a net loss of ₹7.2 Cr for Q2 FY27.
- Key figure
- Net loss ₹7.2 Cr
Mangalam Drugs and Organics Other Announcement
Mangalam Drugs & Organics Ltd has dispatched physical letters to shareholders without registered emails. These letters provide web-links to access the Annual Report for FY 2025-26.
Mangalam Drugs and Organics Management Change
Mangalam Drugs and Organics appointed Prabhakar Raghunath Zavar as Non-Executive Independent Director for 60 months, effective 15 September 2026. The disclosure covers a board-level appointment with a background profile and no monetary amount.
- Execution
- 60 months
Mangalam Drugs and Organics Board Meeting Date
Mangalam Drugs will hold a board meeting on 5 November 2026 to consider unaudited September 2026 quarter results. The agenda is proposed only, pending the meeting.
Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs issued a postal ballot notice seeking approval to re-appoint Praveen Saxena as independent director for a second five-year term. Voting closes 17 June 2026.
Mangalam Drugs and Organics Debt & Borrowing: ₹1,557 Cr
Mangalam Drugs and Organics Limited has reported a default amounting to Rs.1,557.27 Crore. The company has submitted a restructuring proposal to its banks to manage the obligation.
- Value
- ₹1,557 Cr
Other financial results announcements
All →Velox Shipping and Logistics Q2 FY27 Results: Net Profit ₹0.8 Cr, Up 166.7% YoY
Velox Shipping and Logistics Ltd reported revenue from operations of ₹2.5 Cr and net profit of ₹0.8 Cr (+166.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.8 Cr · +166.7% YoY
Ecofinity Atomix Q2 FY27 Results: Net Profit ₹0.7 Cr, Up 16.7% YoY
Ecofinity Atomix Ltd reported revenue from operations of ₹26.5 Cr (+145.4% YoY) and net profit of ₹0.7 Cr (+16.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.7 Cr · +16.7% YoY
Transglobe Foods Q2 FY27 Results: Net Profit ₹0 Cr
Transglobe Foods reported unaudited Q2 and H1 FY27 results for the period ended 30 September 2026. The half-year net loss was ₹3.49 lakhs, with going-concern doubts noted.
- Key figure
- Net profit ₹0 Cr
Euro India Fresh Foods Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Euro India Fresh Foods Ltd reported revenue from operations of ₹29.9 Cr (-8.0% YoY) and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Market Creators Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Market Creators Ltd reported revenue from operations of ₹1.4 Cr (+16.7% YoY) and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Sharma East India Hospitals & Medical Research Q2 FY27 Results: Net Profit ₹0.3 Cr, Up 0.0% YoY
Sharma East India Hospitals & Medical Research Ltd reported revenue from operations of ₹10.4 Cr (+10.6% YoY) and net profit of ₹0.3 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.3 Cr · +0.0% YoY